- Home
- NFG vs BBIO Comparison
NFG vs BBIO Comparison
Compare NFG & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NFG
- BBIO
- Stock Information
- Founded
- NFG 1902
- BBIO 2015
- Country
- NFG United States
- BBIO United States
- Employees
- NFG N/A
- BBIO N/A
- Industry
- NFG Oil/Gas Transmission
- BBIO Biotechnology: Pharmaceutical Preparations
- Sector
- NFG Utilities
- BBIO Health Care
- Exchange
- NFG Nasdaq
- BBIO Nasdaq
- Market Cap
- NFG 6.2B
- BBIO 5.6B
- IPO Year
- NFG N/A
- BBIO 2019
- Fundamental
- Price
- NFG $69.75
- BBIO $36.08
- Analyst Decision
- NFG Buy
- BBIO Strong Buy
- Analyst Count
- NFG 2
- BBIO 13
- Target Price
- NFG $72.50
- BBIO $48.33
- AVG Volume (30 Days)
- NFG 563.8K
- BBIO 2.5M
- Earning Date
- NFG 01-29-2025
- BBIO 02-20-2025
- Dividend Yield
- NFG 2.93%
- BBIO N/A
- EPS Growth
- NFG N/A
- BBIO N/A
- EPS
- NFG 0.84
- BBIO N/A
- Revenue
- NFG $1,944,810,000.00
- BBIO $217,765,000.00
- Revenue This Year
- NFG $26.28
- BBIO $2,309.33
- Revenue Next Year
- NFG $9.85
- BBIO N/A
- P/E Ratio
- NFG $83.03
- BBIO N/A
- Revenue Growth
- NFG N/A
- BBIO 2209.77
- 52 Week Low
- NFG $45.32
- BBIO $21.62
- 52 Week High
- NFG $69.71
- BBIO $41.04
- Technical
- Relative Strength Index (RSI)
- NFG 81.76
- BBIO 73.73
- Support Level
- NFG $60.48
- BBIO $33.73
- Resistance Level
- NFG $61.62
- BBIO $36.24
- Average True Range (ATR)
- NFG 1.07
- BBIO 1.63
- MACD
- NFG 0.93
- BBIO 0.65
- Stochastic Oscillator
- NFG 99.27
- BBIO 97.63
About NFG National Fuel Gas Company
National Fuel Gas Co is a diversified energy company engaged in the production, gathering, transportation, distribution, and marketing of natural gas. The operating segments of the company are the Exploration and Production segment, the Pipeline and Storage segment, the Gathering segment, and the Utility segment. The company generates a majority of its revenue from the Exploration and Production segment which is engaged in the exploration for, and the development and production of, natural gas in the Appalachian region of the United States. Geographically, the company operates in the United States.
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.